Gene-sequencing technique detects drug-resistant strains

08/31/2007 | Bloomberg Businessweek

A group of researchers found that 454 Life Sciences' gene-sequencing technology can detect drug-resistant HIV mutations in patients at levels as low as 1% of the entire virus population in the blood. The application of the technique is expected to improve early detection of resistant strains among HIV patients.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY